Tegretol or Carbamazepine Review

by Norvartis
Tegretol or Carbamazepine
6.95 out of 10 based on 0 user ratings
Tegretol or Carbamazepine
Tegretol or Carbamazepine
Written by: Brain Research Supplements
Date Published: 2011-11-10
6.95 / 10 stars
Tegretol or Carbamazepine  Review

Is Tegretol or Carbamazepine Right For You?

Tegretol (also known as Carbamazepine) is a form of prescription medication that can assist with reducing and controlling epileptic seizures. By successfully being able to control such situations a person may be able to improve his overall quality of life.

Novartis International is the company behind this product. They are located in Switzerland and have a physical address on their site. They also have a phone number for people to call and ask questions. It isn’t a toll-free number though so those calling from other countries may wish to use the online form instead.

This type of medication is only offered through prescription legally. It is never advised to buy it from someone else or to take a prescription that wasn’t meant for you. Many doctors offer free samples of this medication to see how a patient will react to it before they offer a prescription. It is never recommended purchasing Tegretol (or any other prescription drug) from questionable sources.

Ingredients of Tegretol or Carbamazepine

Tegretol or Carbamazepine includes the following ingredients: 5H-dibenz[b,f ]azepine-5-carboxamide (carbamazepine USP), Colloidal silicon dioxide, D&C Red No. 30 Aluminum Lake (chewable tablets only), FD&C Red No. 40 (200-mg tablets only), flavoring (chewable tablets only), gelatin, glycerin, magnesium stearate, sodium starch glycolate (chewable tablets only), starch, stearic acid, and sucrose (chewable tablets only).

Rate this post
shareShare on FacebookShare on Google+Pin on Pinterest
Have a comment or question about Tegretol or Carbamazepine Review?

(Please Note: Comments or questions which include website links or do not contain positive factual language will not be posted.)

Your email address will not be published.